Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
about
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS)The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.Importance of Drug Pharmacokinetics at the Site of ActionGABA Receptors Genes Polymorphisms and Alcohol Dependence: No Evidence of an Association in an Italian Male PopulationPersonalized prescribing: a new medical model for clinical implementation of psychotropic drugs.Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids.DNA methylation in psychosis: insights into etiology and treatment.Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns.Opportunities and limitations: the value of pharmacogenetics in clinical practice.Precision medicine: does ethnicity information complement genotype-based prescribing decisions?Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder.Mechanisms underlying metabolic disturbances associated with psychosis and antipsychotic drug treatment.Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.
P2860
Q28652508-46D70F43-1F83-495D-B3A6-BBC3206D6E85Q33635632-2F69490F-5856-4583-813A-4CC891E22C09Q33648045-7526249A-0B3B-4B54-9B1D-5F6F2FA40D43Q34129857-DA12D35E-84D4-4C36-A1AE-AD1F276ED717Q37344778-02CD5207-30FE-4AFC-A8D9-9F45E837BAD0Q38586847-D0BEED51-4461-46B6-9CBA-A17D7CB3368BQ39038285-BF6FE53D-9757-42DD-BDCB-106F84E5F1F2Q39329159-08B6CAE9-F5DF-47BE-8556-52EE8343E7B3Q42383190-98104885-3F12-40D3-B7AC-D0CE20405B63Q47566249-C2972832-6F57-48D5-986D-03C86756BAB8Q47573171-00E22D1B-DBE9-4CA7-92A5-69AA0B1978CBQ50156396-C7024A8A-7B5A-46F1-9761-8CDFCE5050BFQ52807144-D0E15068-09AB-4014-9EF1-0C1C4DEC434F
P2860
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
@en
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
@nl
type
label
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
@en
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
@nl
prefLabel
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
@en
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
@nl
P2860
P356
P1476
Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.
@en
P2093
Olga O McGowan
P2860
P304
P356
10.1111/BCP.12312
P407
P577
2014-04-01T00:00:00Z